atlab-pharma.com
ATLAB Pharma :: HomeATLAB Pharma develops antibody-targeted radiotherapy for cancer treatment.
http://www.atlab-pharma.com/
ATLAB Pharma develops antibody-targeted radiotherapy for cancer treatment.
http://www.atlab-pharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
le doussal
jean-marc le doussal
56 aven●●●●●●● dufour
Lau●●●nne , 1007
CH
View this contact
le doussal
jean-marc le doussal
56 aven●●●●●●● dufour
Lau●●●nne , 1007
CH
View this contact
Registercom
Domain Registrar
575 8●●●●●venue
New●●●ork , NY, 10018
US
View this contact
BUY YOUR DOMAIN
16
YEARS
8
MONTHS
0
DAYS
REGISTER.COM, INC.
WHOIS : whois.register.com
REFERRED : http://www.register.com
PAGES IN
THIS WEBSITE
8
SSL
EXTERNAL LINKS
2
SITE IP
84.16.73.17
LOAD TIME
0 sec
SCORE
6.2
ATLAB Pharma :: Home | atlab-pharma.com Reviews
https://atlab-pharma.com
ATLAB Pharma develops antibody-targeted radiotherapy for cancer treatment.
atlab-pharma.com
ATLAB Pharma :: ATL-101
http://www.atlab-pharma.com/pipeline_atl101.html
ATL101 is a new targeted radiotherapy drug candidate for treating prostate cancer. ATL101 has shown tolerability profile in a Phase I including 35 patients with metastatic castrate-resistant prostate cancer (mCRPC). ATL101 has shown anti-tumor efficacy in a Phase II including 47 patients with metastatic castrate-resistant prostate cancer (mCRPC). ATL101 is actively studied in various dosage and clinical situations ( ongoing clinical trials.
ATLAB Pharma :: Team
http://www.atlab-pharma.com/about_team.html
ATLAB Pharma was founded in 2008 as a spin-off of Nantes University Cancer Research Center (CRCNA) and Nuclear Medicine Cluster by Jean-Marc Le Doussal, Jean-François Chatal, Jacques Barbet and Stéphane Birklé. Jean-Marc Le Doussal, Founder and President. Jean-François Chatal, Founder and Medical Affairs. ARRONAX, a high energy/high intensity cyclotron for the production of innovative radionuclides for diagnostic and therapeutic use. Jacques Barbet, ATL200 program. Bruno Giroux, Clinical Development.
ATLAB Pharma :: Newsroom
http://www.atlab-pharma.com/news5a.html
Clinical and CTC findings in metastatic castration-resistant prostate cancer patients treated with ATL101, an anti-PSMA radioimmunotherapy, as single-agent and combined with docetaxel presented at ASCO GU 2015. Pr Jean-François Chatal, ATLAB’s Head of Medical Affairs, comments: “These new results confirm the potential of fractionated administration of ATL101 in metastatic cancer patients. Preliminary evidence of cumulative efficacy of docetaxel combination without cumulative toxici...
ATLAB Pharma :: Newsroom
http://www.atlab-pharma.com/news3a.html
Prostate specific membrane antigen (PSMA) imaging as predictive biomarker for anti-PSMA radioimmunotherapy in metastatic castration-resistant prostate cancer patients presented at AACR 2013. Pr Jean-François Chatal, ATLAB’s Head of Medical Affairs, comments: “This preliminary study documents the potential interest in precision medicine and selecting patients for ATL101 radioimmunotherapy on the basis of pre-therapeutic PSMA imaging. However, as only 18% of patients have negative 2D...Non-invasive measure...
ATLAB Pharma :: Newsroom
http://www.atlab-pharma.com/news2a.html
Favorable safety profile and antitumor activity of ATL101 (Lutetium-177 anti-PSMA antibody) in castration-resistant prostate cancer patients presented at ASCO GU 2013. Nantes, France, 15 February 2013 - ATLAB Pharma SAS announces that positive results of a phase II study of ATL101 (Lutetium-177 anti-PSMA antibody) on 47 patients with progressive metastatic castrate-resistant prostate cancer (mCRPC) has been presented at the ASCO 2013 Genitourinary cancer meeting (Orlando FL, USA, 14-16 February 2013).
TOTAL PAGES IN THIS WEBSITE
8
Remora Capital | Portfolio
http://www.remora-partners.com/remora-portfolio.html
Discovers, develops and markets high efficiency biomimetic cosmetic actives for the cosmetic industry. Develops and markets a breast and face simulation software for plastic surgery and aesthetic applications. Develops antibody-based drugs for the targeted radiotherapy of cancer. Develops and markets a monoclonal antibody specific to a form of the GD2 antigen (OAcGD2) for cancer immunotherapy. Develops and markets portable and connected in-vitro diagnostics device derived from CEA research.
Remora Capital | Portfolio
http://www.remora-partners.ch/remora-portfolio.html
Discovers, develops and markets high efficiency biomimetic cosmetic actives for the cosmetic industry. Develops and markets a breast and face simulation software for plastic surgery and aesthetic applications. Develops antibody-based drugs for the targeted radiotherapy of cancer. Develops and markets a monoclonal antibody specific to a form of the GD2 antigen (OAcGD2) for cancer immunotherapy. Develops and markets portable and connected in-vitro diagnostics device derived from CEA research.
TOTAL LINKS TO THIS WEBSITE
2
ATLaaS - Homepage
Oracle CRM On Demand. Why ATLaaS ERP OD. Oracle CRM On Demand. ATLaaS is an innovative Cloud Platform with CRM, Contact Center, ERP and BI- applications pre-integrated. In the cloud, embedded in a Global Telephone and Data Connectivity Network. Integration in the Cloud. Thanks ATLaaS, you will unify your Sales&Marketing Strategy: pre integrated Contact Center, CRM, Campaign Management, Business Intelligence and Voice and Data connectivity infrastructure from one single vendor. Laquo;« (ITA).
User Log In
Redirecting..
ATLA – Asociación de Tintorerías y Lavanderías de Asturias
Siempre Cerca de ti. Asociación de Tintorerias y Lavanderías de Asturias. 8220;Nos encargamos de rentabilizar tu esfuerzo, rápida y eficazmente.”. Confiar en ATLA es tener la garantía del servicio más personal, aunando el buen hacer artesano con al tecnología más avanzada. ATLA nace en 1986, integrando a empresas que suman tradición e innovación a nuestro sector […]. ATLA mantiene convenios con múltiples empresas de prestigio a nivel nacional e internacional […]. La red de ATLA. También puedes localizarl...
ATLAB Pharma :: Home
ATLAB Pharma aims at developing radioimmunotherapy as a breakthrough in cancer treatment. Radioimmunotherapy is a tumor-specific delivery system using monoclonal antibodies conjugated to radioisotopes (radio-antibodies) to target radiation to cancer cells wherever they have disseminated in the body, thus expanding the well-proven efficacy of radiotherapy from localized tumors to metastatic cancers. Prostate specific membrane antigen (PSMA) imaging as predictive biomarker for anti-PSMA radioimmunotherapy ...
Blog de atlab-zahrak - Blog de atlab-zahrak - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Mise à jour :. Abonne-toi à mon blog! N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (67.219.144.170) si quelqu'un porte plainte. Ou poster avec :. Retape dans le champ ci-dessous la suite de chiffres et de lettres qui apparaissent dans le cadre ci-contre. Posté le jeudi 01 décembre 2011 16:09. Ou poster avec :. Que pence 2 7 tof.
welcome to ATLab Inc.
ATL LIMS - Laboratory Information Management System
Accelerated Technology Laboratories, Inc. Biotechnology, CRO and Healthcare. What is a LIMS. ATL is Accelerating Analysis and Growth with Dell. Learn More. Leveraging open architecture and comprehensive automation for laboratories of any size, Sample Master. Accelerates accurate reporting, multiplies productivity, increases operational efficiency, and provides unparalleled data security. Represents the next generation in Laboratory Information Management Systems (LIMS). TITAN. With consumers becoming mor...
Dattatec le informa que su cuenta de hosting ha sido creada en forma exitosa
Iexcl;Tu hosting ya está listo! Esta página se publicó en forma automática para indicar la correcta creación y funcionamiento. De tu nueva cuenta de hosting y brindarte contenido de ayuda para que lo aproveches al máximo. La misma será reemplazada por tu sitio cuando lo publiques. Iquest;Todavía no tienes tu sitio? Crea tu página web en 2 minutos. Tu sitio en 2 minutos! Preparado para móviles y tablets. Tu página web tambien en facebook. Diseños profesionales a tu alcance. Si necesitas ayuda para crearlas.
